Skip to main content
Log in

ATP synthase β-subunit abnormality in pancreas islets of rats with polycystic ovary syndrome and type 2 diabetes mellitus

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

This study investigated the abnormal expression of ATP synthase β-subunit (ATPsyn-β) in pancreas islets of rat model of polycystic ovary syndrome (PCOS) with type 2 diabetes mellitus (T2DM), and the secretion function changes after up-regulation of ATP5b. Sixty female SD rats were divided into three groups randomly and equally. The rat model of PCOS with T2DM was established by free access to the high-carbohydrate/high-fat diet, subcutaneous injections of DHEA, and a single injection of streptozotocin. The pancreas was removed for the detection of the ATPsyn-β expression by immunohistochemical staining, Western blotting and reverse transcription-PCR (RT-PCR). The pancreas islets of the rats were cultured, isolated with collagenase V and purified by gradient centrifugation, and the insulin secretion after treatment with different glucose concentrations was tested. Lentivirus ATP5b was successfully constructed with the vector of GV208 and transfected into the pancreas islets for the over-expression of ATPsyn-β. The insulin secretion and intracellular ATP content were determined after transfection of the PCOS-T2DM pancreas islets with Lenti-ATP5b. The results showed that the expression of ATPsyn-β protein and mRNA was significantly decreased in the pancreas of PCOS-T2DM rats. The ATP content in the pancreas islets was greatly increased and the insulin secretion was improved after the up-regulation of ATPsyn-β in the pancreas islets transfected with lenti-ATP5b. These results indicated that for PCOS, the ATPsyn-β might be one of the key factors for the attack of T2DM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ollila ME, West S, Keinänen-Kiukaanniemi S, et al. Overweight and obese but not normal weight women with PCOS are at increased risk of type 2 diabetes mellitus—a prospective, population-based cohort study. Hum Reprod, 2017,32(2):423–431

    Article  PubMed  Google Scholar 

  2. Moran LJ, Misso ML, Wild RA, et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update, 2010,16(4):347–363

    Article  CAS  PubMed  Google Scholar 

  3. Sim SY, Chin SL, Tan JL, et al. Polycystic ovary syndrome in type 2 diabetes: does it predict a more severe phenotype? Fertil Steril, 2016,106(5):1258–1263

  4. Deugarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril, 2005,83(5):1454–1460

    Article  CAS  PubMed  Google Scholar 

  5. Ashcroft FM, Rorsman P. Diabetes mellitus and the ß cell: The last ten years. Cell, 2012,148(6):1160–1171

    Article  CAS  PubMed  Google Scholar 

  6. Stitzel ML, Kycia I, Kursawe R, et al. Transcriptional regulation of the pancreatic islet: implications for islet function. Curr Diabetes Rep, 2015,15(9):665

    Article  Google Scholar 

  7. Pasquali L, Gaulton KJ, Rodríguez-Seguí SA, et al. Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants. Nat Genet, 2014,46(2):136–143

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lawlor N, Khetan S, Ucar D, et al. Genomics of islet (dys)function and type 2 diabetes. Trends Genet, 2017, DOI: http://dx.doi.org/10.1016/j.tig.2017.01.010. [Epub ahead of print] pii:S0168-9525(17)30021-5.

  9. Szendroedi J, Roden M. Mitochondrial fitness and insulin sensitivity in humans. Diabetologia, 2008,51(12):2155–2167

    Article  CAS  PubMed  Google Scholar 

  10. Hahn A, Parey K, Bublitz M, et al. Structure of a complete ATP synthase dimer reveals the molecular basis of inner mitochondrial membrane morphology. Mol Cell, 2016,63(3):445–456

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Walker JE. Structure and mechanism of ATP syntha-se. BBA-Bioenergetics, 2016,1587:3

    Article  Google Scholar 

  12. Singh KB. Persistent estrus rat models of polycystic ovary disease: an update. Fertil Steril, 2005,84(Suppl 2):1228–1234

    Article  PubMed  Google Scholar 

  13. Walters KA, Allan CM. Rodent models for human polycystic ovary syndrome. Biol Reprod, 2012,86(5):1–12

    Article  Google Scholar 

  14. Mannerås L, Cajander S, Holmäng A, et al. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology, 2007,148(8):3781–3791

    Article  PubMed  Google Scholar 

  15. Shi DN, Vine DF. Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk. Fertil Steril, 2012,98(1):185–193

    Article  PubMed  Google Scholar 

  16. Zhai HL, Wu H, Xu H, et al. Trace glucose and lipid metabolism in high androgen and high-fat diet induced polycystic ovary syndrome rats. Reprod Biol Endocrin, 2012,10(1):55

    Article  Google Scholar 

  17. Srinivasan K, Viswanad B, Asrat L, et al. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res, 2005,52(4):313–320

    Article  CAS  PubMed  Google Scholar 

  18. Teede HJ, Hutchison S, Zoungas S. Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS. Endocrine, 2006,30(1):45–53

    Article  CAS  PubMed  Google Scholar 

  19. Petersen KF, Dufour S, Shulman GI. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLOS Med, 2005,2(9):879–884

    Article  CAS  Google Scholar 

  20. Dong KL, Ni H, Wu ML, et al. ROS-mediated glucose metabolic reprogram induces insulin resistance in type 2 diabetes. Biochem Bioph Res C, 2016,476(4):204–211

    Article  CAS  Google Scholar 

  21. Grapengießser E, Dansk H, Hellman B. Pulses of external ATP aid to the synchronization of pancreatic ß-cells by generating premature Ca2+ oscillations. Biochem Pharmacol, 2004,68(4):667–674

    Article  Google Scholar 

  22. Fujimoto S, Nabe K, Takehiro M, et al. Impaired metabolism-secretion coupling in pancreatic beta-cells: role of determinants of mitochondrial ATP production. Diabetes Res Clin Pr, 2007,77(Suppl 1):S2–S10

    Article  CAS  Google Scholar 

  23. Wang L, Xu F, Zhang XJ, et al. Effect of high-fat diet on cholesterol metabolism in rats and its association with Na+/K+-ATPase/Src/Perk signaling pathway. J Huazhong Univ Sci Technolog Med Sci, 2015,35(4):490–494

    Article  CAS  PubMed  Google Scholar 

  24. Saleh MC, Fatehi-Hassanabad Z, Wang R, et al. Mutated ATP synthase induces oxidative stress and impaired insulin secretion in beta-cells of female BHE/cdb rats. Diabetes-Metab Res, 2008,24(5):392–403

    Article  CAS  Google Scholar 

  25. Pedersen PL. Transport ATPases into the year 2008: a brief overview related to types, structures, functions and roles in health and disease. J Bioenerg Biomembr, 2007,39(5):349–355

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jing Yang  (杨 菁).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, W., Li, Sj., Yin, Tl. et al. ATP synthase β-subunit abnormality in pancreas islets of rats with polycystic ovary syndrome and type 2 diabetes mellitus. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 37, 210–216 (2017). https://doi.org/10.1007/s11596-017-1717-9

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-017-1717-9

Key words

Navigation